Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-05-30
2006-05-30
Desai, Rita (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S119000
Reexamination Certificate
active
07053103
ABSTRACT:
This invention relates to compounds which are generally CRF-1 receptor antagonists and which are represented by Formula I or Formula II:wherein Ar is optionally substituted aryl or heteroaryl, R1–R4are as defined in the specification; or individual isomers, racemic or non-racemic mixtures of isomers, or pharmaceutically acceptable salts thereof. The invention further relates to processes for preparing such compounds, to pharmaceutical compositions containing such compounds, and to methods for their use as therapeutic agents.
REFERENCES:
patent: 5668145 (1997-09-01), Bright
patent: 5705646 (1998-01-01), Bright et al.
patent: 5712303 (1998-01-01), Faraci et al.
patent: 5760225 (1998-06-01), Yuan
patent: 6200979 (2001-03-01), Bright et al.
Hehemann, et al., “Addition of Diamines to Methylthiopyridones,”J. Heterocyclic Chem., (1994), pp. 393-396, vol. 31 (2).
Mohareb, et al., “Reactions with 4-Phenyl-3-thiosemicarbazide: A New Approach for the Synthesis of Pyrazole, Thiazole, Pyridine and Pyrazolo[3,4-b]- Pyridine Derivatives,”Sulfur Letters, (1991), pp. 101-113, vol. 13 (3).
Chemstar Ltd, Moscow, Russia, Database Chemcats 'online! Chemical Abstracts Service, Columbus, Ohio, US; retrieved from STN XP-002233223, Order Nos.: CHS 0390519; CHS 0053761, dated May 16, 2001.
Asinex, Moscow, Russia, Database Chemcats 'online! Chemical Abstracts Service, Columbus, Ohio, US; retrieved from STN XP-002233224, Order No.: BAS 0138479, dated May 10, 2001.
Specs and Biospecs B.V., Rijswijk, NL, Database Chemcats 'online! Chemical Abstracts Service, Columbus, Ohio, US; retrieved from STN XP-002233225, Order No.: AG-667/12449002 & “Compounds for Screening”, dated Jul. 1, 2001.
Ambinter, Paris, France, Database Chemcats 'online! Chemical Abstracts Service, Columbus, Ohio, US; retrieved from STN XP-002233226, Order Nos.:132-45219; 132-45159; 132-45157; 132-45155; Stock1S-39093, Stock1S-34168; dated Jan. 21, 2002.
Loughhead David Garrett
O'Yang Counde
Buckwalter Brian L.
Desai Rita
Syntex (U.S.A.) LLC
LandOfFree
Ring fused pyrazole derivatives as CRF antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Ring fused pyrazole derivatives as CRF antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Ring fused pyrazole derivatives as CRF antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3644781